Delivery Order SPE2DR25D2206-SPE2DR26F9FB0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This firm fixed-price delivery order, valued at $3,512.48, represents a non-competitive set-aside and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,027.91 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of October 27, 2025. The award was made on October 24, 2025, with performance occurring at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,022.83 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity 6 units). This competitive, non-set-aside award was executed on November 3, 2025, with an ultimate completion date of November 4, 2025, under a firm fixed-price contract type. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Nitazoxanide 500 mg tablets in packages of six, with a ceiling value of $1,685.10 and a firm fixed price structure. This non-set-aside competitive award is scheduled for completion by November 28, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $3,477.04 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six. The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award...
- The Defense Logistics Agency awarded a delivery order valued at $3,212.33 to AmerisourceBergen Drug Corp for Nitazoxanide 500 mg tablets in quantities of six, with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract was awarded on August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiprotozoal and antiviral medication commonly used to treat parasitic and infectious...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Nitazoxanide 500 mg tablets and has a ceiling value of $2,631.89. It is a firm fixed-price delivery order contract with a completion date of July 3, 2025. The contract is not set aside and is awarded as an open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The contract is for the delivery of 500 mg nitazoxanide tablets with a completion date of February 21, 2024 and a potential value of $5,055.24. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,563.48 firm-fixed-price contract is for the supply of 4,567,278,099 tablets of the drug Nitazoxanide 500 mg. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITAZOXANIDE 500 MG TABLET 6S, with a ceiling value of $25,209.40 and a performance period through May 21, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FB0Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets in quantities of 6 units, with a ceiling value of $12,378.20. This firm fixed-price delivery order, issued on December 9, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of December 10, 2025. The place of performance is located at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications and medical supplies to military healthcare programs and other federal healthcare systems. The Nitazoxanide procurement supports the Defense Health Agency's pharmaceutical supply requirements, consistent with the company's extensive portfolio of generic and brand-name drug deliveries across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 12/8/25 |